Reexamining the evidence for inpatient glucose control: New recommendations for glycemic targets

被引:21
作者
Moghissi, Etie S. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Amer Assoc Clin Endocrinologists Inpatient Task F, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
关键词
Critical illness; Dosage schedule; Hospitals; Hyperglycemia; Insulin; Insulins; Protocols; Toxicity; ACUTE MYOCARDIAL-INFARCTION; INTENSIVE INSULIN THERAPY; ASSOCIATION CONSENSUS STATEMENT; CLINICAL ENDOCRINOLOGISTS; AMERICAN ASSOCIATION; HOSPITAL MORTALITY; DIABETES-MELLITUS; WOUND-INFECTION; CARE-UNIT; HYPERGLYCEMIA;
D O I
10.2146/ajhp100171
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Purpose. To review the risks of hyperglycemia in hospitalized patients, data supporting the benefits of treating hyperglycemia, and recommendations from the 2009 American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on the management of inpatient hyperglycemia. Summary. Inpatient hyperglycemia is common, costly, and associated with poor clinical outcomes in many disease states. Despite inconsistencies in clinical trial results, good glucose management in the hospital remains important. Target blood glucose concentrations (BGs) were recently modified to somewhat higher values with the expectation that the benefit of treatment will persist with a lower risk of hypoglycemia, which is itself another marker of poor outcome in critically and noncritically ill patients. In the intensive care unit (ICU), the threshold to start treatment is a BG of 5180 mg/dL. I.V. insulin is the treatment of choice in critically ill patients because of its rapid onset and offset of action. Once i.v. insulin is started, the BG should be maintained between 140 and 180 mg/dL; a lower BG target (110-140 mg/dL) may be appropriate in selected patients. Targets of <110 mg/dL or >180 mg/dL are no longer recommended. In noncritically ill patients, premeal BG targets are <140 mg/dL; random BGs of <180 mg/dL are recommended. Scheduled subcutaneous insulin is the treatment of choice for hyperglycemia in noncritically ill patients; use of sliding-scale insulin is strongly discouraged. To avoid hypoglycemia, insulin regimens should be reassessed if BG falls to <100 mg/dL. Conclusion. Poor glycemic control in the hospital setting is a quality-of-care, safety, and cost issue. Safe and effective strategies to implement optimal glycemic control require multidisciplinary involvement. Insulin given i.v. in the ICU or subcutaneously on an as-scheduled regimen in other parts of the hospital is the treatment of choice.
引用
收藏
页码:S3 / S8
页数:6
相关论文
共 41 条
[1]
ACE/ADA Task Force on Inpatient Diabetes, 2006, Endocr Pract, V12, P458
[2]
The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes [J].
Ainla, T ;
Baburin, A ;
Teesalu, R ;
Rahu, M .
DIABETIC MEDICINE, 2005, 22 (10) :1321-1325
[3]
[Anonymous], 2005, DIABETES CARE, V28, pS4
[4]
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease [J].
Baker, EH ;
Janaway, CH ;
Philips, BJ ;
Brennan, AL ;
Baines, DL ;
Wood, DM ;
Jones, PW .
THORAX, 2006, 61 (04) :284-289
[5]
Intensive insulin therapy and pentastarch resuscitation in severe sepsis [J].
Brunkhorst, Frank M. ;
Engel, Christoph ;
Bloos, Frank ;
Meier-Hellmann, Andreas ;
Ragaller, Max ;
Weiler, Norbert ;
Moerer, Onnen ;
Gruendling, Matthias ;
Oppert, Michael ;
Grond, Stefan ;
Olthoff, Derk ;
Jaschinski, Ulrich ;
John, Stefan ;
Rossaint, Rolf ;
Welte, Tobias ;
Schaefer, Martin ;
Kern, Peter ;
Kuhnt, Evelyn ;
Kiehntopf, Michael ;
Hartog, Christiane ;
Natanson, Charles ;
Loeffler, Markus ;
Reinhart, Konrad .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) :125-139
[6]
CAPES SE, 2004, INTENS CARE MED, V30, P748
[7]
*CDCP, 2006, DISTR 1 LIST DIAGN H
[8]
Centers for Disease Control and Prevention, 2007, NAT DIAB SHEET
[9]
The hyperglycemia: Intensive insulin infusion in infarction (HI-5) study - A randomized controlled trial of insulin infusion therapy for myocardial infarction [J].
Cheung, NW ;
Wong, VW ;
McLean, M .
DIABETES CARE, 2006, 29 (04) :765-770
[10]
Management of diabetes and is hyperglycemia in hospitals [J].
Clement, S ;
Braithwaite, SS ;
Magee, MF ;
Ahmann, A ;
Smith, EP ;
Schafer, RG ;
Hirsh, IB .
DIABETES CARE, 2004, 27 (02) :553-591